dr. J.C. Oosterwijk

No picture available
E-mail:
j.c.oosterwijk umcg.nl

Research

  1. 2010
  2. Aten, E., Brasz, L. C., Bornholdt, D., Hooijkaas, I. B., Porteous, M. E., Sybert, V. P., ... den Dunnen, J. T. (2010). Keratosis Follicularis Spinulosa Decalvans Is Caused by Mutations in MBTPS2. Human Mutation, 31(10), 1125-1133. https://doi.org/10.1002/humu.21335
  3. Walker, L. C., Fredericksen, Z. S., Wang, X., Tarrell, R., Pankratz, V. S., Lindor, N. M., ... SWE-BRCA (2010). Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast cancer research, 12(6), [102]. https://doi.org/10.1186/bcr2785
  4. 2009
  5. Mohammadi, L., Vreeswijk, M. P., Oldenburg, R., van den Ouweland, A., Oosterwijk, J. C., van der Hout, A. H., ... van Houwelingen, H. C. (2009). A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example. BMC Cancer, 9, [211]. https://doi.org/10.1186/1471-2407-9-211
  6. Garcia, E. B. G., Oosterwijk, J. C., Timmermans, M., van Asperen, C. J., Hogervorst, F. B. L., Hoogerbrugge, N., ... Vreeswijk, M. P. G. (2009). A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history. Breast cancer research, 11(1), [8]. https://doi.org/10.1186/bcr2223
  7. 2008
  8. 2007
  9. Kriege, M., Brekelmans, C. T. M., Peterse, H., Obdeijn, I. M., Boetes, C., Zonderland, H. M., ... Klijn, J. G. M. (2007). Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Research and Treatment, 102(3), 357-363. https://doi.org/10.1007/s10549-006-9341-6
  10. 2006
  11. Kriege, M., Brekelmans, C. T. M., Obdeijn, I. M., Boetes, C., Zonderland, H. M., Muller, S. H., ... Klijn, J. G. M. (2006). Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Research and Treatment, 100(1), 109-119. https://doi.org/10.1007/s10549-006-9230-z
  12. Bodmer, D., Ligtenberg, M. J. L., van der Hout, A. H., Gloudemans, S., Ansink, K., Oosterwijk, J. C., & Hoogerbrugge, N. (2006). Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of ' easy to apply ' probability models. British Jounal of Cancer, 95(6), 757-762. https://doi.org/10.1038/sj.bjc.6603306
  13. van der Hout, A. H., van den Ouweland, AMW., van der Luijt, RB., Gille, HJP., Bodmer, D., Bruggenwirth, H., ... Hofstra, R. M. W. (2006). A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: Application in a Dutch cancer clinic setting. Human Mutation, 27(7), 654-666. https://doi.org/10.1002/humu.20340
  14. 2005
  15. Tilanus-Linthorst, M. M. A., Kriege, M., Boetes, C., Hop, W. C. J., Obdeijn, I-M., Oosterwijk, J. C., ... Brekelmans, C. T. M. (2005). Hereditary breast cancer growth rates and its impact on screening policy. European Journal of Cancer, 41(11), 1610-1617. https://doi.org/10.1016/j.ejca.2005.02.034
  16. Callenbach, PMC., van den Boogerd, EH., de Coo, RFM., ten Houten, R., Oosterwijk, JC., Hageman, G., ... van den Maagdenberg, AMJM. (2005). Refinement of the chromosome 16 locus for benign familial infantile convulsions. Clinical Genetics, 67(6), 517-525. https://doi.org/10.1111/j.1399-0004.2005.00445.x
  17. Stalmeier, PFM., Roosmalen, MS., Verhoef, LCG., Hoekstra-Weebers, JEHM., Oosterwijk, JC., Moog, U., ... van Daal, WAJ. (2005). The decision evaluation scales. Patient Education and Counseling, 57(3), 286-293. https://doi.org/10.1016/j.pec.2004.07.010
  18. Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., ... Klijn, J. G. M. (2005). Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition. Obstetrical & Gynecological Survey, 60(2), 107-109. https://doi.org/10.1097/01.ogx.0000151669.38495.2e
  19. Oosterwijk, J. C., & Ausems, M. G. E. M. (2005). Trends binnen de klinische genetica. Medisch Contact, 60, 1880-1883.
  20. 2004
  21. Dobyns, WB., Filauro, A., Tomson, BN., Chan, AS., Ho, AW., Ting, NT., ... Ober, C. (2004). Inheritance of most X-linked traits is not dominant or recessive, just X-linked. American Journal of Medical Genetics. Part A, 129A(2), 136-143. https://doi.org/10.1002/ajmg.20004.a.30123
  22. Kriege, M., Brekelmans, CTM., Boetes, C., Besnard, PE., Zonderland, HM., Obdeijn, IM., ... Magnetic Resonance Imaging Screeni (2004). Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. New England Journal of Medicine, 351(5), 427-437.
  23. van Roosmalen, MS., Stalmeier, PFM., Verhoef, LCG., Hoekstra-Weebers, JEHM., Oosterwijk, JC., Hoogerbrugge, N., ... van Daal, W. (2004). Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. British Jounal of Cancer, 90(2), 333-342. https://doi.org/10.1038/sj.bjc.6601525
  24. 2003
  25. 2002
  26. 2001
  27. Kriege, M., Brekelmans, C. T., Boetes, C., Rutgers, E. J., Oosterwijk, J. C., Tollenaar, R. A., ... Klijn, J. G. (2001). MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC). Familial Cancer, 1(3-4), 163-8.
  28. 2000
  29. 1999
  30. Hoogerwaard, EM., van der Wouw, PA., Wilde, AAM., Bakker, E., Ippel, PF., Oosterwijk, JC., ... de Visser, M. (1999). Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscular disorders, 9(5), 347-351.
  31. de Bock, GH., Vlieland, TPMV., Hageman, GCHA., Oosterwijk, JC., Springer, MP., & Kievit, J. (1999). The assessment of genetic risk of breast cancer: a set of GP guidelines. Family practice, 16(1), 71-77.

ID: 124551